Unfavourable impact of growth hormone (GH) discontinuation on body composition and cholesterol profiles after the completion of height growth in GH-deficient young adults

Diabetes, Obesity and Metabolism

Volumn 1, Issue 5, 1999, Pages 293-296

  Kohno, H ^a   Ueyama, N ^a   Honda, S ^a  

^a FUKUOKA CHILDREN S HOSPITAL   (Japan)

Author keywords

Body composition; Cholesterol profiles; Growth hormone discontinuation

Indexed keywords

CHOLESTEROL; HUMAN GROWTH HORMONE;

ADOLESCENT; ADULT; ARTICLE; BLOOD; BODY COMPOSITION; BODY CONSTITUTION; BODY HEIGHT; BODY MASS; BODY WEIGHT; HUMAN; MALE;

ADOLESCENT; ADULT; BODY COMPOSITION; BODY CONSTITUTION; BODY HEIGHT; BODY MASS INDEX; BODY WEIGHT; CHOLESTEROL; HUMAN GROWTH HORMONE; HUMANS; MALE;

EID: 0033188481     PISSN: 14628902     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1463-1326.1999.00048.x     Document Type: Article

References (21)

1. Wabitsch M, Heinze E. Body fat in GH-deficient children and the effect of treatment. Horm Res 1993; 40: 5-9.
2. Kohno H, Ueyama N, Yanai S, Ukaji K, Honda S. Beneficial effect of growth hormone on atherogenic risk in children with growth hormone deficiency. J Pediatrics 1995; 126: 953-955.
3. Hassan HMS, Kohno H, Kuromaru R, Honda S, Ueda K. Body composition, atherogenic risk factors and apolipoproteins following growth hormone treatment. Acta Paediatr 1996; 85: 899-901.
4. Jorgensen JOL, Pedersen SA, Thuesen L et al. Beneficial effects of growth hormone treatment in GH-deficient adults. Lancet, 1989; I: 1221-1225.
5. Salomon F, Cuneo RC, Heps R, Sonksen PH. The effects of treatment with recombinant human growth hormone on body composition and metabolism in adults with growth hormone deficiency. N Engl J Med 1989; 321: 1797-1803.
6. Bengsson B-A, Eden S, Lonn L et al. Treatment of adults with growth hormone (GH) deficiency with recombinant human GH. J Clin Endocrinol Metab 1993; 76: 309-317.
7. Markussis V, Beshyah Y, Fisher C, Sharp P, Nicolaides AN, Johnston DG. Detection of premature atherosclerosis by high-resolution ultrasonography in symptom-free hypopituitary adults. Lancet 1992; 340: 1188-1192.
8. Rosen T, Bengtsson BA. Premature mortality due to cardiovascular disease in hypopituitarism. Lancet 1990; 336: 285-288.
9. Houtkooper L, Going SB, Lohman TG, Roche AF, Loan MV. Bioelectrical impedance estimation of fat-free body mass in children and youth: a cross-validation study. J Appl Physiol 1992; 72: 366-373.
10. Castelli WP, Abbott RD, McNamara PM. Summary estimates of cholesterol used to predict coronary heart disease. Circulation 1983; 67: 730-734.
11. Rosenbaum M, Gertner JM, Leibel RL. Effects of systemic growth hormone (GH) administration on regional adipose tissue distribution and metabolism in GH-deficient children. J Clin Endocrinol Metab 1989; 69: 1274-1281.
12. Van der Werff ten Bosch JJ, Bot A. Effects of human pituitary growth hormone on body composition. Neth J Med 1987; 30: 220-227.
13. Colle M, Auzerie J. Discontinuation of growth hormone therapy in growth-hormone-deficient patients: assessment of body fat mass using bioelectrical impedance. Horm Res 1993; 39: 192-196.
14. Rutherford OM, Jones DA, Round JM, Buchanan CR, Preece MA. Changes in skeletal muscle and body composition after discontinuation of growth hormone treatment in growth hormone deficient young adults. Clin Endocrinol 1991; 34: 469-475.
15. Frindik JP, Kemp SF, Elders MJ, Morris M. The effect of growth hormone on lipid profiles of growth hormone deficient children. J Pediatr Endocrinol 1989; 3: 167-170.
16. Rosen T, Johannsson G, Hallgren P, Caidahl C, Bosaeus I, Bengtsson B-A. Beneficial effects of 12 months replacement therapy with recombinant human growth hormone to growth hormone deficient adults. Endocrinol Metab 1994; 1: 55-66.
17. Blackett PR, Weech PK, MacConathy WJ, Fesmire JD. Growth hormone in regulation of hyperlipidemia. Metabolism 1982; 31: 117-120.
18. Irie M, Shizume K, Takano K et al. Growth hormone replacement therapy in adults with growth hormone deficiency: a double-blind, placebo-controlled crossover trial in Japan. Endocrinol Metab 1995; 2 (Suppl): 17-23.
19. Levine GN, Keaney JF, Vita JA. Cholesterol reduction in cardiovascular disease: clinical benefits and possible mechanisms. N Engl J Med 1995; 332: 512-521.
20. Capaldo B, Patti L, Oliviero U et al. Increased arterial intima-media thickness in childhood-onset growth hormone deficiency. J Clin Endocrinol Metab 1997; 82: 1378-1381.
21. Ho KKY, Hoffman DM. Aging and growth hormone. Horm Res 1993; 40: 80-86.